Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd., Singapore, Singapore – FDA Inspections

Inspection records and compliance data for Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. in Singapore. 5 FDA inspections on record, last inspected February 20, 2020.

Company Profile

This profile covers Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. based in Singapore, Singapore.

FDA Inspection History

FDA inspections: 5
OAI: 0
VAI: 0
NAI: 4
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected November 11, 2011. Last inspected February 20, 2020.

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
February 20, 2020	NAI	Human Drugs · Drug Quality Assurance	1275696
December 7, 2018	NAI	Human Drugs · Drug Quality Assurance	1076633
February 14, 2017	Not classified	Human Drugs	1016851
September 26, 2014	NAI	Human Drugs · Drug Quality Assurance	897244
November 11, 2011	NAI	Human Drugs · Drug Quality Assurance	756562

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

LILLY CENTRE FOR CLINICAL PHARMACOLOGY PTE LTD

Beecham Pharmaceuticals (Site #1)

Licht Far East (Singapore) Pte Ltd

SGS Testing and Controls Services Singapore Pte. Ltd.

Andrew Ross Lai Kit Soo

Pua Loong Trading Company

Drug Houses Of Australia Pte Ltd

Noel M. Varghese, M.B.B.S

Labcorp Development (Asia) Pte. Ltd

Barnaby Young, M.D.